Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 6, 2018
Jan 16, 2018 21:05 pm UTC| Business
MILPITAS, Calif., Jan. 16, 2018 -- Nanometrics Incorporated (NASDAQ:NANO), a leading provider of advanced process control systems, will release its fourth quarter and full year 2017 financial results after market close...
TTM Technologies, Inc. To Conduct Fourth Quarter 2017 Conference Call February 7th, 2018
Jan 16, 2018 21:05 pm UTC| Business
COSTA MESA, Calif., Jan. 16, 2018 -- TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, February 7th at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its fourth quarter 2017...
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
Jan 16, 2018 21:05 pm UTC| Business
RA’ANANA, Israel and NEW YORK, Jan. 16, 2018 -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...
Impinj to Announce Fourth Quarter and Year 2017 Financial Results
Jan 16, 2018 21:04 pm UTC| Business
SEATTLE, Jan. 16, 2018 -- Impinj, Inc. (NASDAQ:PI), a leading provider and pioneer of RAIN RFID solutions for identifying, locating and authenticating everyday items, today announced it will release financial results...
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
Jan 16, 2018 21:01 pm UTC| Business
REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 16, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG;...
Jan 16, 2018 21:01 pm UTC| Business
CAMBRIDGE, Mass., Jan. 16, 2018 -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company that discovers and develops novel cancer vaccines, announced today that it intends to offer and sell in concurrent...
Obalon Therapeutics Announces Proposed Public Offering of Common Stock
Jan 16, 2018 21:01 pm UTC| Business
SAN DIEGO, Jan. 16, 2018 -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma